SUMMARYIt is shown that the administration of a course of antilymphocytic globulin (ALG) significantly decreased the efficacy of a subsequent course in prolonging allograft survival. It was also found that survival of a second allograft was significantly less in rats treated with ALG at the time of this graft whether, at the time of the primary graft, they were or were not given ALG.